Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medius Holdings Co., Ltd. (3154:JPX), powered by AI.
Medius Holdings Co., Ltd. is currently trading at ¥855. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medius Holdings Co., Ltd. on Alpha Lenz.
Medius Holdings Co., Ltd.'s P/E ratio is 13.8.
“Medius Holdings Co., Ltd. trades at a P/E of 13.8 (undervalued) with modest ROE of 6.8%.”
Ask for details →Medius Holdings Co., Ltd. is a Japanese company primarily engaged in the manufacture and wholesale distribution of health and wellness products. Its primary function is to develop and supply a diverse range of healthcare and fitness equipment, nutritional supplements, and wellness-related goods, catering to increasing consumer demand for health-conscious living. Medius Holdings plays a significant role in the health and wellness industry, impacting sectors such as medical devices, personal health care, and rehabilitation services. The company is known for its innovation and quality, ensuring that its products meet stringent industry standards, thereby gaining trust among its clientele, which includes both individual consumers and healthcare institutions. In the financial market, Medius Holdings Co., Ltd. holds a position as a key player within the health consumer goods sector in Japan, reflecting trends of an aging population and rising lifestyle-related health concerns. Consequently, Medius Holdings is influential in shaping how healthcare solutions are accessed and utilized across various communities.
“Medius Holdings Co., Ltd. trades at a P/E of 13.8 (undervalued) with modest ROE of 6.8%.”
Ask for details →Medius Holdings Co., Ltd. (ticker: 3154) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 2,614 employees. Market cap is $19.0B.
The current price is 855 with a P/E ratio of 13.81x and P/B of 0.93x.
ROE is 6.84% and operating margin is 0.65%. Annual revenue is $288.7B.